Comparing Popular Cancer Screening Services: Cost, Access, and Convenience

As they say, it’s complicated. When doing a cancer screening services comparison, consumers care about cost. One of the biggest drivers of cost is your insurance coverage. As you probably are aware, insurance benefits and available plan types change daily, and this question may not even matter to you if you are one of the 27.2 million Americans without health insurance, according to the CDC.[4]

Insurance companies typically cover cancer screening tests and services recommended by the United States Preventive Services Task Force (USPSTF). They do so to meet Affordable Care Act requirements.[5] Of some of the most popular screening tests, the USPTF recommends only [6]:

• BRCA genetic cancer screening (only for people with personal or familial high-risk history)
• FIT Colon Cancer Screening test (or other types of stool testing kits) for people 45-75 years old

Direct-to-consumer cancer screening tests should not replace routinely recommended cancer screenings such as mammograms, colonoscopies, or HPV and pap tests for cervical cancer.[7]

Genetic screening tests look for inherited gene changes, called mutations, that increase the risk of developing certain types of cancer. Well-known examples of genetic cancer screening tests are [8]:

• Genetic testing for breast cancer
• Multi-gene hereditary panel tests, like those that test for familial cancer syndromes like Lynch Syndrome

Genetic cancer screening tests are most often recommended (and covered by insurance) when you have specific risk factors or a family history with red flags, such as [8]:

• Cancers diagnosed at a young age.
• Several different types of cancer occurred in the same person.
• Cancer diagnosed in multiple family members, particularly with patterns such as several first-degree relatives with the same type of cancer.
• Being a member of a racial or ethnic group that is known to have an increased risk of having a certain inherited cancer susceptibility syndrome, such as being of Ashkenazi Jewish descent.

Other cancer screening services can be considered “popular” because more people have them than genetic cancer screenings. They aren’t popular in the sense that people actually like to have these screenings (hello, painful mammogram squeeze!), but they are more likely to have the routine screenings because their insurance covers all or part of the cost. Also, regular screening brings peace of mind. According to the U.S. Preventive Services Task Force, examples of these popular cancer screening services are [6]:

• Mammograms
• Colorectal cancer screening
• HPV tests and pap smears
• Limited CT-scans for lung cancer in people 50 to 80 years of age with a 20-pack-year history

It is possible, over time, once the newer direct-to-consumer genetic screening tests like Galleri® become approved by the FDA, that they will be incorporated into USPTF screening guidelines and be covered by more insurance companies.[9] Galleri® has more clinical trials and research demonstrating the validity of its ability to test for what it claims to test for than other tests, such as CancerGuard.[10]

There is another reason why people may choose Galleri® over CancerGuard. Galleri® has more clinical research data that shows its ability to identify where in the body cancer might be if you have a positive test result.[9] Galleri® and CancerGuard test for biomarkers of cancer, not actual cancer cells. They test for fragments of genetic material, called cell-free DNA, that cancer cells shed. These biomarkers may differ depending on whether they come from the prostate or the breast, for example.

Grail, the maker of Galleri®, reported an accuracy of 90%, meaning that out of every 100 times it identifies a biomarker from breast tissue, it will actually be linked to breast tissue 90 times.[9] Large research trials show that Galleri® accurately predicts cancers in the right tissue at a higher rate than CancerGuard.[9]

You are a smart healthcare consumer who likes to be informed. Everlywell knows that, so we delivered this cancer screening services comparison just for you. There are also many more helpful blogs on cancer prevention and screening under the “Learn” tab. Questions about which colon cancer screening test is right for you? Your answers are there. Need a guide for prostate cancer screenings? We’ve got you.

By making some of the best cancer screening services available to you from your home, Everlywell makes staying cancer-free more accessible and convenient. Plus, Everlywell offers virtual care visits with nurse practitioners who can help you address your symptoms or cancer screening questions with the right test and the right cancer prevention strategies. You don’t have to figure out the ins and outs of cancer prevention and screening on your own. Everlywell is here to make it easier for you.

Sources

1. Saving lives by eliminating costs of early detection of prostate cancer. ZERO Prostate Cancer. Published 2025. Accessed March 3, 2026. https://zerocancer.org/take-action/advocate/policy-priorities/early-detection-prostate-cancer-eliminating-costs-screening.
2. How much does genetic testing for breast cancer cost? Aflac. Accessed March 3, 2026. https://www.aflac.com/resources/cancer-insurance/genetic-testing-for-breast-cancer-cost.aspx.
3. American Cancer Society guideline for colorectal cancer screening. American Cancer Society. Accessed March 3, 2026.https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/acs-recommendations.html
4. U.S. Uninsured rate drops by 15% since 2020. National Center for Healthcare Statistics (NCHC). June 24, 2025. Accessed March 3, 2026. https://www.cdc.gov/nchs/pressroom/releases/20250624.html.
5. Preventive services covered by private health plans under the Affordable Care Act. Kaiser Family Foundation. February 28, 2024. Accessed March 2, 2026. https://www.kff.org/womens-health-policy/preventive-services-covered-by-private-health-plans/
6. U.S. Preventive Services Task Force. Adult Preventive Health Care Schedule: Recommendations from the USPSTF (as of May 9, 2023). American Academy of Family Physicians. Published 2023. Accessed March 3, 2026.https://www.aafp.org/dam/AAFP/documents/journals/afp/USPSTFHealthCareSchedule2023.pdf.
7. Multicancer early detection tests (MCDs). American Cancer Society. Accessed March 3, 2026. https://www.cancer.org/cancer/screening/multi-cancer-early-detection-tests.html.
8. Genetic testing for inherited cancer risk fact sheet. National Cancer Institute. Updated April 18, 2024. Accessed March 3, 2026. https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheet#what-genetic-tests-are-available-for-inherited-cancer-risk.
9. Eisenstein M. Putting cancer detection to the test. Nature. 2025;d41586-025-00530-4. doi:10.1038/d41586-025-00530-4.
10. Ofman J, Hall MP, Clarke-Dur C. Not all MCED tests are created equal: the realities of MCED test development and validation. GRAIL. Published July 31, 2025. Accessed March 3, 2026. https://grail.com/stories/not-all-mced-tests-are-created-equal-the-realities-of-mced-test-development-and-validation/.